Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Prediction using hierarchical data: Applications for automated detection of cervical cancer.

Yamal JM, Guillaud M, Atkinson EN, Follen M, MacAulay C, Cantor SB, Cox DD.

Stat Anal Data Min. 2015 Apr;8(2):65-74. Epub 2015 Apr 8.

2.

A statistical model for removing inter-device differences in spectroscopy.

Wang L, Lee JS, Lane P, Atkinson EN, Zuluaga A, Follen M, MacAulay C, Cox DD.

Opt Express. 2014 Apr 7;22(7):7617-24. doi: 10.1364/OE.22.007617.

3.

Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia without colposcopic tissue information; a step toward automation for low resource settings.

Yamal JM, Zewdie GA, Cox DD, Atkinson EN, Cantor SB, MacAulay C, Davies K, Adewole I, Buys TP, Follen M.

J Biomed Opt. 2012 Apr;17(4):047002. doi: 10.1117/1.JBO.17.4.047002.

4.

Optical technologies and molecular imaging for cervical neoplasia: a program project update.

Buys TP, Cantor SB, Guillaud M, Adler-Storthz K, Cox DD, Okolo C, Arulogon O, Oladepo O, Basen-Engquist K, Shinn E, Yamal JM, Beck JR, Scheurer ME, van Niekerk D, Malpica A, Matisic J, Staerkel G, Atkinson EN, Bidaut L, Lane P, Benedet JL, Miller D, Ehlen T, Price R, Adewole IF, MacAulay C, Follen M.

Gend Med. 2012 Feb;9(1 Suppl):S7-24. doi: 10.1016/j.genm.2011.08.002. Epub 2011 Sep 22.

5.

Detection of microcalcifications on digital screening mammograms using varying degrees of monitor zooming.

Haygood TM, Arribas E, Liu QM, Atkinson EN, Brennan PC, Santiago L, Carkaci S, Lane D, Stephens TW, LePetross H, Adrada B, Davis P, Whitman GJ.

AJR Am J Roentgenol. 2011 Oct;197(4):W761-8. doi: 10.2214/AJR.10.5238.

PMID:
21940549
6.

An empirical model of diagnostic x-ray attenuation under narrow-beam geometry.

Mathieu KB, Kappadath SC, White RA, Atkinson EN, Cody DD.

Med Phys. 2011 Aug;38(8):4546-55.

7.

A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma.

Lacour RA, Euscher E, Atkinson EN, Sun CC, Ramirez PT, Coleman RL, Brown J, Gano JB, Burke TW, Ramondetta LM.

Int J Gynecol Cancer. 2011 Apr;21(3):517-22. doi: 10.1097/IGC.0b013e31820da9e2.

PMID:
21436700
8.

Repeatability of tissue fluorescence measurements for the detection of cervical intraepithelial neoplasia.

Yamal JM, Cox DD, Atkinson EN, Macaulay C, Price R, Follen M.

Biomed Opt Express. 2010 Aug 19;1(2):641-657.

9.

A new approach for identifying patients with ovarian epithelial neoplasms based on high-resolution mass spectrometry.

Silva EG, Lopez PR, Atkinson EN, Fente CA.

Am J Clin Pathol. 2010 Dec;134(6):903-9. doi: 10.1309/AJCPG91UXBYFNRVO.

PMID:
21088153
10.

Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy.

Cantor SB, Yamal JM, Guillaud M, Cox DD, Atkinson EN, Benedet JL, Miller D, Ehlen T, Matisic J, van Niekerk D, Bertrand M, Milbourne A, Rhodes H, Malpica A, Staerkel G, Nader-Eftekhari S, Adler-Storthz K, Scheurer ME, Basen-Engquist K, Shinn E, West LA, Vlastos AT, Tao X, Beck JR, Macaulay C, Follen M.

Int J Cancer. 2011 Mar 1;128(5):1151-68. doi: 10.1002/ijc.25667. Epub 2010 Nov 9.

11.

Interpretation time of computer-aided detection at screening mammography.

Tchou PM, Haygood TM, Atkinson EN, Stephens TW, Davis PL, Arribas EM, Geiser WR, Whitman GJ.

Radiology. 2010 Oct;257(1):40-6. doi: 10.1148/radiol.10092170. Epub 2010 Aug 2.

PMID:
20679448
12.

Conspicuity of microcalcifications on digital screening mammograms using varying degrees of monitor zooming.

Haygood TM, Arribas E, Brennan PC, Atkinson EN, Herndon M, Dieber J, Geiser W, Santiago L, Mills CM, Davis P, Adrada B, Carkaci S, Stephens TW, Whitman GJ.

Acad Radiol. 2009 Dec;16(12):1509-17. doi: 10.1016/j.acra.2009.07.010.

PMID:
19896068
13.

Why does it take longer to read digital than film-screen screening mammograms? A partial explanation.

Haygood TM, Wang J, Lane D, Galvan E, Atkinson EN, Stephens T, Whitman GJ.

J Digit Imaging. 2010 Apr;23(2):170-80. doi: 10.1007/s10278-009-9177-9. Epub 2009 Feb 13.

14.

Model-based analysis of reflectance and fluorescence spectra for in vivo detection of cervical dysplasia and cancer.

Redden Weber C, Schwarz RA, Atkinson EN, Cox DD, Macaulay C, Follen M, Richards-Kortum R.

J Biomed Opt. 2008 Nov-Dec;13(6):064016. doi: 10.1117/1.3013307.

15.

Timed efficiency of interpretation of digital and film-screen screening mammograms.

Haygood TM, Wang J, Atkinson EN, Lane D, Stephens TW, Patel P, Whitman GJ.

AJR Am J Roentgenol. 2009 Jan;192(1):216-20. doi: 10.2214/AJR.07.3608.

16.

Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma.

Euscher ED, Malpica A, Atkinson EN, Levenback CF, Frumovitz M, Deavers MT.

Am J Surg Pathol. 2008 Sep;32(9):1336-43. doi: 10.1097/PAS.0b013e31816ecfe4.

PMID:
18670356
17.

Results of a survey on digital screening mammography: prevalence, efficiency, and use of ancillary diagnostic AIDS.

Haygood TM, Whitman GJ, Atkinson EN, Nikolova RG, Sandoval SY, Dempsey PJ.

J Am Coll Radiol. 2008 Apr;5(4):585-92. doi: 10.1016/j.jacr.2007.10.019.

PMID:
18359447
18.

Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer.

Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP 3rd, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM.

Clin Cancer Res. 2008 Jan 1;14(1):224-9. doi: 10.1158/1078-0432.CCR-07-0733.

19.

Accuracy of colposcopy in the diagnostic setting compared with the screening setting.

Cantor SB, Cárdenas-Turanzas M, Cox DD, Atkinson EN, Nogueras-Gonzalez GM, Beck JR, Follen M, Benedet JL.

Obstet Gynecol. 2008 Jan;111(1):7-14. doi: 10.1097/01.AOG.0000295870.67752.b4.

PMID:
18165387
20.

The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial neoplasia: where are we?

Cardenas-Turanzas M, Freeberg JA, Benedet JL, Atkinson EN, Cox DD, Richards-Kortum R, MacAulay C, Follen M, Cantor SB.

Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S138-46. Review.

PMID:
17908588
21.

The clinical effectiveness of fluorescence and reflectance spectroscopy for the in vivo diagnosis of cervical neoplasia: an analysis by phase of trial design.

Freeberg JA, Benedet JL, West LA, Atkinson EN, MacAulay C, Follen M.

Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S270-80. Epub 2007 Sep 7. Review.

PMID:
17825882
22.

Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy.

Ohtani S, Iwamaru A, Deng W, Ueda K, Wu G, Jayachandran G, Kondo S, Atkinson EN, Minna JD, Roth JA, Ji L.

Cancer Res. 2007 Jul 1;67(13):6293-303.

23.

Fluorescence and reflectance device variability throughout the progression of a phase II clinical trial to detect and screen for cervical neoplasia using a fiber optic probe.

Freeberg JA, Serachitopol DM, McKinnon N, Price R, Atkinson EN, Cox DD, MacAulay C, Richards-Kortum R, Follen M, Pikkula B.

J Biomed Opt. 2007 May-Jun;12(3):034015.

24.

Instrumentation as a source of variability in the application of fluorescence spectroscopic devices for detecting cervical neoplasia.

Pikkula BM, Shuhatovich O, Price RL, Serachitopol DM, Follen M, McKinnon N, MacAulay C, Richards-Kortum R, Lee JS, Atkinson EN, Cox DD.

J Biomed Opt. 2007 May-Jun;12(3):034014.

25.

Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.

Badgwell D, Lu Z, Cole L, Fritsche H, Atkinson EN, Somers E, Allard J, Moore RG, Lu KH, Bast RC Jr.

Gynecol Oncol. 2007 Sep;106(3):490-7. Epub 2007 May 25.

26.

A translational bioengineering course provides substantial gains in civic scientific literacy.

Richards-Kortum R, Buckley D, Schwarz RA, Atkinson EN, Follen M.

Ann Biomed Eng. 2007 Aug;35(8):1324-32. Epub 2007 Apr 26.

PMID:
17458698
27.

Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer.

Lu Z, Luo RZ, Peng H, Rosen DG, Atkinson EN, Warneke C, Huang M, Nishmoto A, Liu J, Liao WS, Yu Y, Bast RC Jr.

Clin Cancer Res. 2006 Apr 15;12(8):2404-13.

28.

Calibration standards for multicenter clinical trials of fluorescence spectroscopy for in vivo diagnosis.

Marín NM, MacKinnon N, MacAulay C, Chang SK, Atkinson EN, Cox D, Serachitopol D, Pikkula B, Follen M, Richards-Kortum R.

J Biomed Opt. 2006 Jan-Feb;11(1):014010.

29.

Objective assessment of aesthetic outcomes of breast cancer treatment: measuring ptosis from clinical photographs.

Kim MS, Reece GP, Beahm EK, Miller MJ, Atkinson EN, Markey MK.

Comput Biol Med. 2007 Jan;37(1):49-59. Epub 2006 Jan 24.

PMID:
16438948
30.

New tumor markers: CA125 and beyond.

Bast RC Jr, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, Baggerly KA, Atkinson EN, Skates S, Zhang Z, Lokshin A, Menon U, Jacobs I, Lu K.

Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:274-81. Review.

31.

Interactive dynamic graphical techniques for the exploration of functional data.

Atkinson EN, Follen M.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S76-83. Epub 2005 Oct 7.

PMID:
16214205
32.

Results of a pilot study of multispectral digital colposcopy for the in vivo detection of cervical intraepithelial neoplasia.

Milbourne A, Park SY, Benedet JL, Miller D, Ehlen T, Rhodes H, Malpica A, Matisic J, Van Niekirk D, Atkinson EN, Hadad N, Mackinnon N, Macaulay C, Richards-Kortum R, Follen M.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S67-75. Epub 2005 Oct 3.

PMID:
16202444
33.

Classification using the cumulative log-odds in the quantitative pathologic diagnosis of adenocarcinoma of the cervix.

Swartz RJ, West LA, Boiko I, Malpica A, Guillaud M, Macaulay C, Follen M, Atkinson EN, Cox DD.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S24-31. Epub 2005 Sep 26.

PMID:
16185757
34.

Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: qualitative histopathologic analysis and methodologic issues.

Malpica A, Matisic JP, Niekirk DV, Crum CP, Staerkel GA, Yamal JM, Guillaud MH, Cox DD, Atkinson EN, Adler-Storthz K, Poulin NM, Macaulay CA, Follen M.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S38-52. Epub 2005 Sep 23.

PMID:
16183106
35.

Optical technologies for cervical neoplasia: update of an NCI program project grant.

Follen M, Crain S, MacAulay C, Basen-Engquist K, Cantor SB, Cox D, Atkinson EN, MacKinnon N, Guillaud M, Richards-Kortum R.

Clin Adv Hematol Oncol. 2005 Jan;3(1):41-53. Review.

PMID:
16166967
36.

Cervical chromosome 9 polysomy: validation and use as a surrogate endpoint biomarker in a 4-HPR chemoprevention trial.

Kim HG, Yamal JM, Xu XC, Hu W, Boiko I, Linares A, Vlastos AT, Atkinson EN, Malpica A, Hittelman WN, Follen M.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S32-7. Epub 2005 Sep 9.

PMID:
16154183
37.

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M, Atkinson EN, Smith DI, Hartmann L, Fishman D, Berchuck A, Whitaker R, Gershenson DM, Mills GB, Bast RC Jr, Lu KH.

Clin Cancer Res. 2005 Sep 1;11(17):6116-26.

38.

Age and FSH effects in fluorescence spectra from the cervix: an exploratory analysis.

Atkinson EN.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S95-7. Epub 2005 Sep 6.

PMID:
16143375
39.

Natural history of cervical intraepithelial neoplasia: a meta-analysis.

Cantor SB, Atkinson EN, Cardenas-Turanzas M, Benedet JL, Follen M, MacAulay C.

Acta Cytol. 2005 Jul-Aug;49(4):405-15.

PMID:
16124170
40.

Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.

Eder AM, Sui X, Rosen DG, Nolden LK, Cheng KW, Lahad JP, Kango-Singh M, Lu KH, Warneke CL, Atkinson EN, Bedrosian I, Keyomarsi K, Kuo WL, Gray JW, Yin JC, Liu J, Halder G, Mills GB.

Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12519-24. Epub 2005 Aug 22.

41.

Combined reflectance and fluorescence spectroscopy for in vivo detection of cervical pre-cancer.

Chang SK, Mirabal YN, Atkinson EN, Cox D, Malpica A, Follen M, Richards-Kortum R.

J Biomed Opt. 2005 Mar-Apr;10(2):024031.

42.

Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix.

Jenkins AD, Ramondetta LM, Sun C, Johnston T, Wolf JK, Bodurka DC, Brown J, Atkinson EN, Levenback C.

Gynecol Oncol. 2005 Jun;97(3):840-4.

PMID:
15882895
43.

Predictors of breast and cervical screening in Vietnamese women in Harris County, Houston, Texas.

Ho V, Yamal JM, Atkinson EN, Basen-Engquist K, Tortolero-Luna G, Follen M.

Cancer Nurs. 2005 Mar-Apr;28(2):119-29; quiz 130-1.

PMID:
15815181
44.

Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3.

Vlastos AT, West LA, Atkinson EN, Boiko I, Malpica A, Hong WK, Follen M.

Clin Cancer Res. 2005 Jan 1;11(1):390-6.

45.

A pilot study for a screening trial of cervical fluorescence spectroscopy.

Nath A, Rivoire K, Chang S, West L, Cantor SB, Basen-Engquist K, Adler-Storthz K, Cox DD, Atkinson EN, Staerkel G, MacAulay C, Richards-Kortum R, Follen M.

Int J Gynecol Cancer. 2004 Nov-Dec;14(6):1097-107.

PMID:
15571615
46.

The effects of repeated spectroscopic pressure measurements on fluorescence intensity in the cervix.

Rivoire K, Nath A, Cox D, Atkinson EN, Richards-Kortum R, Follen M.

Am J Obstet Gynecol. 2004 Nov;191(5):1606-17.

PMID:
15547531
47.

Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo.

Ito I, Ji L, Tanaka F, Saito Y, Gopalan B, Branch CD, Xu K, Atkinson EN, Bekele BN, Stephens LC, Minna JD, Roth JA, Ramesh R.

Cancer Gene Ther. 2004 Nov;11(11):733-9.

PMID:
15486560
48.
49.

Effect of probe pressure on cervical fluorescence spectroscopy measurements.

Nath A, Rivoire K, Chang S, Cox D, Atkinson EN, Follen M, Richards-Kortum R.

J Biomed Opt. 2004 May-Jun;9(3):523-33.

50.

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.

Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I, Smith D, Hartmann L, Fishman D, Berchuck A, Schmandt R, Whitaker R, Gershenson DM, Mills GB, Bast RC Jr.

Clin Cancer Res. 2004 May 15;10(10):3291-300.

Supplemental Content

Loading ...
Support Center